Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Miltefosine for PKDL in Children in Bangladesh
NCT02193022Phase 3Completed
- Sponsor
- icddr,b
- Start
- Jul 2014
- Primary completion
- Jun 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of miltefosine in Post kala-azar dermal leishmaniasis (PKDL), sponsored by icddr,b. Started Jul 2014; status: completed.
02
Drugs
miltefosine
03
Conditions
Post kala-azar dermal leishmaniasis (PKDL)
Beyond the preview
Go deeper on NCT02193022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02193022.